Consolidated Statements of Operations - USD ($)	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development	$ 11,639,411	$ 11,287,691
General and administrative	7,493,035	9,742,739
Total operating expenses	19,132,446	21,030,430
Loss from operations	(19,132,446)	(21,030,430)
Other income (expense):
Investment income, net	512,204	1,157,625
Loss on debt extinguishment		(329,158)
Interest expense		(197,080)
Other expense		(396,319)
Total other income (expense), net	512,204	235,068
Loss before income tax benefit	(18,620,242)	(20,795,362)
Income tax benefit		1,280,385
Net loss	$ (18,620,242)	$ (19,514,977)
Net loss per common share - Basic	$ (1.62)	$ (2.16)
Net loss per common share - Diluted	$ (1.62)	$ (2.16)
Weighted average common shares outstanding - Basic	11,508,159	9,045,320
Weighted average common shares outstanding - Diluted	11,508,159	9,045,320

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.